CD40 activation induces NREM sleep and modulates genes associated with sleep homeostasis

Brain, Behavior, and Immunity

Volumn 27, Issue 1, 2013, Pages 133-144

  Gast, Heidemarie ^a   Müller, Andreas ^b   Lopez, Martin ^b   Meier, Daniel ^b   Huber, Reto ^c   Dechent, Frieder ^d   Prinz, Marco ^d   Emmenegger, Yann ^e   Franken, Paul ^e   Birchler, Thomas ^b   Fontana, Adriano ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

AIDS; Brain endothelial cells; Depression; Human immunodeficiency virus (HIV); Inflammatory bowel disease; Microglia; Multiple sclerosis; Rheumatoid arthritis; Sickness behavior

Indexed keywords

CD40 ANTIGEN; EARLY GROWTH RESPONSE FACTOR 2; ETANERCEPT; FOS LIKE ANTIGEN 2; IMMUNOGLOBULIN G2A; PENTRAXIN 2; PROTEIN; PROTEIN HOMER 1A; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; BRAIN CORTEX; CD3+ T LYMPHOCYTE; CEREBELLUM; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FRONTAL CORTEX; GENE EXPRESSION; IMMUNITY; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEEP WAKING CYCLE; WEIGHT REDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; AUTOIMMUNE DISEASES; BRAIN; C-REACTIVE PROTEIN; CARRIER PROTEINS; EARLY GROWTH RESPONSE PROTEIN 2; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FOS-RELATED ANTIGEN-2; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM; SLEEP, REM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870758415     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.10.004     Document Type: Article

References (70)

1. Advani R., Forero-Torres A., Furman R.R., Rosenblatt J.D., Younes A., Ren H., Harrop K., Whiting N., Drachman J.G. Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma. J. Clin. Oncol. 2009, 27:4371-4377.
2. Banks W.A., Moinuddin A., Morley J.E. Regional transport of TNF-alpha across the blood-brain barrier in young ICR and young and aged SAMP8 mice. Neurobiol Aging. 2001, 22:671-676.
3. Baracchi F., Opp M.R. Sleep-wake behavior and responses to sleep deprivation of mice lacking both interleukin-1 beta receptor 1 and tumor necrosis factor-alpha receptor 1. Brain Behav. Immun. 2008, 22:982-993.
4. Bluthe R.M., Laye S., Michaud B., Combe C., Dantzer R., Parnet P. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur. J. Neurosci. 2000, 12:4447-4456.
5. Blair P.A., Chavez-Rueda K.A., Evans J.G., Shlomchik M.J., Eddaoudi A., Isenberg D.A., Ehrenstein M.R., Mauri C. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for suppression of lupus in MRL/lpr mice. J. Immunol. 2009, 182:3492-3502.
6. Borbely A.A., Achermann P. Sleep homeostasis and models of sleep regulation. J. Biol. Rhythms 1999, 14:557-568.
7. Braun J., McHugh N., Singh A., Wajdula J.S., Sato R. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50mg once-weekly and 25mg twice-weekly. Rheumatology (Oxford) 2007, 46:999-1004.
8. Bredow S., Guha-Thakurta N., Taishi P., Obál F., Krueger J.M. Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain. NeuroImmunoModulation 1997, 4:84-90.
9. Cavadini G., Petrzilka S., Kohler P., Jud C., Tobler I., Birchler T., Fontana A. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. USA 2007, 104:12843-12848.
10. Clegg C.H., Rulffes J.T., Haugen H.S., Hoggatt I.H., Aruffo A., Durham S.K., Farr A.G., Hollenbaugh D. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. Int. Immunol. 1997, 9:1111-1122.
11. Cirelli C. The genetic and molecular regulation of sleep: from fruit flies to humans. Nat. Rev. Neurosci. 2009, 10:549-560.
12. Cunningham C., Campion S., Teeling J., Felton L., Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav. Immun. 2007, 21:490-502.
13. Danese S., de la Motte C., Reyes B.M., Sans M., Levine A.D., Fiocchi C. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J. Immunol. 2004, 172:2011-2015.
14. Dann A., Poeck H., Croxford A.L., Gaupp S., Kierdorf K., Knust M., Pfeifer D., Maihoefer C., Endres S., Kalinke U., Meuth S.G., Wiendl H., Knobeloch K.P., Akira S., Waisman A., Hartmann G., Prinz M. Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat Neurosci. 2011, 15:98-106.
15. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
16. Datta S.C., Opp M.R. Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP® technology. J. Neurosci. Methods 2008, 175:119-124.
17. Easton A., Meerlo P., Bergmann B., Turek F.W. The suprachiasmatic nucleus regulates sleep timing and amount in mice. Sleep 2004, 27:1307-1318.
18. Elgueta R., Benson M.J., de Vries V.C., Wasiuk A., Guo Y., Noelle R.J. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 2009, 229:152-172.
19. Erickson M.A., Banks W.A. Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav. Immun. 2011, 25:1637-1648.
20. Farahani P., Levine M., Gaebel K., Wang E.C., Khalidi N. Community-based evaluation of etanercept in patients with rheumatoid arthritis. J. Rheumatol. 2006, 33:665-670.
21. Floyd R.A., Krueger J.M. Diurnal variation of TNF alpha in the rat brain. NeuroReport 1997, 8:915-918.
22. Franken P., Chollet D., Tafti M. The homeostatic regulation of sleep need is under genetic control. J. Neurosci. 2001, 21:2610-2621.
23. Franken P., Malafosse A., Tafti M. Genetic determinants of sleep regulation in inbred mice. Sleep 1999, 22:155-169.
24. Franken P., Dijk D.J. Circadian clock genes and sleep homeostasis. Eur. J. Neurosci. 2009, 29:1820-1829.
25. Franklin C.M. Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis. Semin. Arthritis Rheum. 1999, 29:172-181.
26. Furman R.R., Forero-Torres A., Shustov A., Drachman J.G. A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia. Leuk. Lymphoma 2010, 51:228-235.
27. Grewal I.S., Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 1998, 16:111-135.
28. Hasan S., Pradervand S., Ahnaou A., Drinkenburg W., Tafti M., Franken P. How to keep the brain awake? The complex molecular pharmacogenetics of wake promotion. Neuropsychopharmacology 2009, 34:1625-1640.
29. Heiberg M.S., Koldingsnes W., Mikkelsen K., Rodevand E., Kaufmann C., Mowinckel P., Kvien T.K. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study. Arthritis Rheum. 2008, 59:234-240.
30. Horiuchi T., Mitoma H., Harashima S., Tsukamoto H., Shimoda T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 2010, 49:1215-1228.
31. Huber R., Tononi G., Cirelli C. Exploratory behavior, cortical BDNF expression, and sleep homeostasis. Sleep 2007, 30:129-139.
32. Hussein M., Berenson J.R., Niesvizky R., Munshi N., Matous J., Sobecks R., Harrop K., Drachman J.G., Whiting N. A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma. Haematologica 2010, 95:845-848.
33. Iaboni A., Ibanez D., Gladman D.D., Urowitz M.B., Moldofsky H. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. J. Rheumatol. 2006, 33:2453-2457.
34. Imeri L., Bianchi S., Opp M.R. Inhibition of caspase-1 in rat brain reduces spontaneous nonrapid eye movement sleep and nonrapid eye movement sleep enhancement induced by lipopolysaccharide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R197-R204.
35. Kapás L., Bohnet S.G., Traynor T.R., Majde J.A., Szentirmai E., Magrath P., Taishi P., Krueger J.M. Spontaneous and influenza virus-induced sleep are altered in TNF-alpha double-receptor deficient mice. J. Appl. Physiol. 2008, 105:1187-1198.
36. Kimura K., Moriwaki H., Nagaki M., Saio M., Nakamoto Y., Naito M., Kuwata K., Chisari F.V. Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease. Am. J. Pathol. 2006, 168:786-795.
37. Krueger J.M. The role of cytokines in sleep regulation. Curr. Pharm. Des. 2008, 14:3408-3416.
38. Kubota T., Fang J., Guan Z., Brown R.A., Krueger J.M. Vagotomy attenuates tumor necrosis factor-alpha-induced sleep and EEG delta-activity in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R1213-R1220.
39. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J. Neurochem. 1999, 73:309-321.
40. Laposky A., Easton A., Dugovic C., Walisser J., Bradfield C., Turek F. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep 2005, 28:395-409.
41. Lichtenstein G.R., Bala M., Han C., DeWoody K., Schaible T. Infliximab improves quality of life in patients with Crohn's disease. Inflamm. Bowel Dis. 2002, 8:237-243.
42. Mackiewicz M., Paigen B., Naidoo N., Pack A.I. Analysis of the QTL for sleep homeostasis in mice. Homer1a is a likely candidate. Physiol. Genomics 2008, 33:91-99.
43. Maret S., Dorsaz S., Gurcel L., Pradervand S., Petit B., Pfister C., Hagenbuchle O., O'Hara B.F., Franken P., Tafti M. Homer1a is a core brain molecular correlate of sleep loss. Proc. Natl. Acad. Sci. USA 2007, 104:20090-20095.
44. Moreland L.W., Genovese M.C., Sato R., Singh A. Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis. Arthritis Rheum. 2006, 55:287-293.
45. Morita S., Miyata S. Different vascular permeability between the sensory and secretory circumventricular organs of adult mouse brain. Cell Tissue Res. 2012, 349:589-603.
46. Naidoo N., Ferber M., Galante R.J., McShane B., Hu J.H., Zimmerman J., Maislin G., Cater J., Wyner A., Worley P., Pack A.I. Role of Homer proteins in the maintenance of sleep-wake states. PLoS ONE 2012, 7(4):e35174.
47. Nelson S.E., Duricka D.L., Campbell K., Churchill L., Krueger J.M. Homer1a and 1bc levels in the rat somatosensory cortex vary with the time of day and sleep loss. Neurosci. Lett. 2004, 367:105-108.
48. Opp M.R. Cytokines and sleep. Sleep Med. Rev. 2005, 9:355-364.
49. Palchykova S., Winsky-Sommerer R., Shen H.Y., Boison D., Gerling A., Tobler I. Manipulation of adenosine kinase affects sleep regulation in mice. J. Neurosci. 2010, 30:13157-13165.
50. Peppel K., Crawford D., Beutler B. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 1991, 174:1483-1489.
51. Peters A.L., Stunz L.L., Bishop G.A. CD40 and autoimmunity: the dark side of a great activator. Semin. Immunol. 2009, 21:293-300.
52. Petrzilka S., Taraborrelli C., Cavadini G., Fontana A., Birchler T. Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling. J. Biol. Rhythms 2009, 24:283-294.
53. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
54. Ramirez S.H., Fan S., Dykstra H., Reichenbach N., Del Valle L., Potula R., Phipps R.P., Maggirwar S.B., Persidsky Y. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis. J. Neurosci. 2010, 30:9454-9464.
55. Rolink A., Melchers F., Andersson J. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 1996, 5:319-330.
56. Serra P., Amrani A., Yamanouchi J., Han B., Thiessen S., Utsugi T., Verdaguer J., Santamaria P. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 2003, 19:877-889.
57. Shoham S., Davenne D., Cady A.B., Dinarello C.A., Krueger J.M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am. J. Physiol. 1987, 253:R142-R149.
58. Shurety W., Pagan J.K., Prins J.B., Stow J.L. Endocytosis of uncleaved tumor necrosis factor-alpha in macrophages. Lab. Invest. 2001, 81:107-117.
59. Song Z., Jin R., Yu S., Rivet J.J., Smyth S.S., Nanda A., Granger D.N., Li G. CD40 is essential in the upregulation of TRAF proteins and NF-kappaB-dependent proinflammatory gene expression after arterial injury. PLoS ONE 2011, 6:e23239.
60. Sui Z., Sniderhan L.F., Schifitto G., Phipps R.P., Gelbard H.A., Dewhurst S., et al. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J. Immunol. 2007, 178:3226-3236.
61. Taishi P., Churchill L., Wang M., Kay D., Davis C.J., Guan X., et al. TNFalpha siRNA reduces brain TNF and EEG delta wave activity in rats. Brain Res. 2007, 1156:125-132.
62. Takahashi S., Kapas L., Seyer J.M., Wang Y., Krueger J.M. Inhibition of tumor necrosis factor attenuates physiological sleep in rabbits. NeuroReport 1996, 7:642-646.
63. Takahashi S., Kapás L., Fang J., Seyer J.M., Wang Y., Krueger J.M. An interleukin-1 receptor fragment inhibits spontaneous sleep and muramyl dipeptide-induced sleep in rabbits. Am. J. Physiol. 1996, 271:R101-R108.
64. Taraborrelli C., Palchykova S., Tobler I., Gast H., Birchler T., Fontana A. TNFR1 is essential for CD40, but not for lipopolysaccharide-induced sickness behavior and clock gene dysregulation. Brain Behav. Immun. 2011, 25:434-442.
65. Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006, 367:29-35.
66. van Loo G., De Lorenzi R., Schmidt H., Huth M., Mildner A., Schmidt-Supprian M., Lassmann H., Prinz M.R., Pasparakis M. Nat Immunol. 2006, 7:954-961.
67. Vgontzas A.N., Zoumakis E., Lin H.M., Bixler E.O., Trakada G., Chrousos G.P. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J. Clin. Endocrinol. Metab. 2004, 89:4409-4413.
68. Vowinkel T., Wood K.C., Stokes K.Y., Russell J., Krieglstein C.F., Granger D.N. Differential expression and regulation of murine CD40 in regional vascular beds. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H631-H639.
69. Wiley J.A., Harmsen A.G. Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation. Am. J. Pathol. 1999, 154:919-926.
70. Yoshida H., Peterfi Z., Garcia-Garcia F., Kirkpatrick R., Yasuda T., Krueger J.M. State-specific asymmetries in EEG slow wave activity induced by local application of TNFalpha. Brain Res. 2004, 1009:129-136.